|
EIF2C3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.945900E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.802000E-01 |
| Normal-vs-Stage2 |
4.788000E-01 |
| Normal-vs-Stage3 |
7.282400E-02 |
| Normal-vs-Stage4 |
4.378400E-02 |
| Stage1-vs-Stage2 |
9.058200E-01 |
| Stage1-vs-Stage3 |
3.315600E-01 |
| Stage1-vs-Stage4 |
2.207600E-01 |
| Stage2-vs-Stage3 |
6.509800E-01 |
| Stage2-vs-Stage4 |
5.003800E-01 |
| Stage3-vs-Stage4 |
7.366400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.773370E-01 |
| Normal-vs-AfricanAmerican |
1.161880E-04 |
| Normal-vs-Asian |
1.978220E-01 |
| Caucasian-vs-AfricanAmerican |
1.080540E-03 |
| Caucasian-vs-Asian |
2.008200E-01 |
| AfricanAmerican-vs-Asian |
6.378500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.758400E-03 |
| Normal-vs-Female |
5.926000E-01 |
| Male-vs-Female |
1.831170E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.993150E-01 |
| Normal-vs-Age(41-60Yrs) |
4.037600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.755600E-02 |
| Normal-vs-Age(81-100Yrs) |
3.486800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.758400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.639000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.342800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.680390E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.778400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.719000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.727600E-01 |
| Normal-vs-Grade 2 |
7.415000E-01 |
| Normal-vs-Grade 3 |
4.161700E-02 |
| Normal-vs-Grade 4 |
3.224000E-03 |
| Grade 1-vs-Grade 2 |
6.090000E-01 |
| Grade 1-vs-Grade 3 |
2.142400E-01 |
| Grade 1-vs-Grade 4 |
4.527900E-02 |
| Grade 2-vs-Grade 3 |
7.262500E-02 |
| Grade 2-vs-Grade 4 |
5.103800E-03 |
| Grade 3-vs-Grade 4 |
2.081600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.838790E-01 |
| Normal-vs-ccB subtype |
4.455900E-03 |
| ccA subtype-vs-ccB subtype |
4.70490000004098E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.431800E-01 |
| Normal-vs-N1 |
1.986260E-02 |
| N0-vs-N1 |
1.998960E-01 |
|
|
